INTRODUCTION 71
Dehydration associated with heat stress (i.e., a progressive loss of body water through 72 sweating without adequate fluid replacement) is known to cause marked impairments in 73 cardiovascular and thermoregulatory control (14, 30) . Dehydration is associated with a state of 74 both hypovolemia and hyperosmolality, and therefore simultaneously implicates both 75 baroreceptor unloading (via reductions in blood volume) and osmoreceptor activation. However, 76 the vast majority of studies have considered these effects separately with respect to the regulation 77 of the heat loss responses (i.e., skin blood flow and sweating). Hyperosmolality alone exerts a 78 central modulation of thermoregulatory activity via increases the core temperature onset 79 threshold for both sweating and cutaneous vasodilation during whole body passive heat stress (2, 80 11, 24, 31, 36) and exercise (8) without affecting the thermosensitivity of the response. 81
Moreover, hypovolemia simulated with lower body negative pressure (LBNP) application during 82 passive heat stress can independently delay the onset threshold for cutaneous vasodilation with 83 no effect on sweating (24). Hypovolemia induced via reductions in blood volume during exercise 84 (i.e., through profuse sweating) can reduce the thermosensitivity of sweating (7) as well as peak 85 forearm blood flow (8, 28) . 86
To our knowledge, only two studies have assessed the combined effects of 87 hyperosmolality and hypovolemia on the heat loss responses, and these have been limited to 88 passive heat stress (16, 24) . Examining solely the skin blood flow response, Ito et al. (16) 89 demonstrated greater reductions in forearm vascular conductance when graded levels of LBNP 90 were applied in a hyperosmotic state compared to an isosmotic state. The study by Lynn et al. 91 (24) demonstrated a parallel response such that the attenuation of skin blood flow during 92 hyperosmolality or LBNP alone was exacerbated when their effects were combined. 93 Nonthermal modulators of postexercise heat loss responses breath oxygen uptake was measured by an automated gas analyzer (Medgraphics Ultima, 163 Medical Graphics Crop., St Paull, MN, USA). 164
Preliminary session. This session was included to establish the magnitude of total body 165 fluid loss for each individual associated with the exercise protocol. Participants were asked to 166 complete 45-min of brisk treadmill walking (60% of VO 2peak ) in a thermal chamber Environmental Systems, Markham, ON, Canada) set at 35°C and 30% relative humidity while 168 wearing a loosely fitted poncho covering the torso only. While the room was set to 30% relative 169 humidity, the poncho was employed to reduce the water vapour pressure gradient between the 170 skin and the impermeable layer which helped to maximize sweat production, and therefore total 171 body fluid loss. To ensure that the appropriate intensity was maintained, oxygen consumption 172 was monitored throughout exercise by measuring expired oxygen and carbon dioxide 173 concentrations (AMETEK model S-3A/1 and CD3A, Applied Electrochemistry, Pittsburgh, PA, 174 USA). Speed and incline changes were carefully recorded for each participant such that the 175 exercise protocol could be replicated to induce a similar body water loss in the five experimental 176 sessions (see below). A measurement of nude body mass was obtained prior to and immediately 177 following treadmill exercise to determine total body fluid loss. 178
Experimental sessions. For each experimental session, participants reported to the 179 laboratory at the same time of day. Upon arrival, they were instructed to provide a urine sample 180 and to change into shorts and running shoes. A nude body mass was obtained after euhydration 181 was verified using urine specific gravity (1). An 18-gauge venous catheter was inserted in the 182 antecubital fossa vein and connected to a Luer Lock extension [LifeShield Inc., Lake Forest, IL, USA)] while participants rested supine. They were then instrumented in a 185 Nonthermal modulators of postexercise heat loss responses thermoneutral room and transferred to a thermal chamber set at 35°C and 30% relative humidity. 186
After 15-min of upright seated baseline resting, participants donned a poncho and replicated the 187 45-min treadmill exercise protocol performed in the preliminary session. Noteworthy, the left 188 arm was stabilized at the level of the heart throughout the treadmill exercise in order to prevent 189 extravasation of the venous catheter. Following exercise, participants were immediately 190 transferred without being wiped dry (~5-min) to an upright-seated pressure box sealed at the 191 level of the iliac crests using custom-made, loose fitting neoprene shorts. Thereafter, participants 192 were re-instrumented for the measurement of blood pressuring using a Finometer and remained 193 seated for 60-min of recovery. At the end of the experimental session, nude body mass and a 194 urine sample were obtained. 195 This study consisted of five experimental conditions. In conditions #1 and #2, 196 participants received either an isotonic (0.9% NaCl, ISO) or hypertonic (3.0% NaCl, HYP) 197 infusion of saline (warmed to near body temperature) for the duration of the exercise protocol 198 Instruments, Austin, TX, USA) and recorded in spreadsheet format on a desktop computer. 227
Local sweat rate was measured at the chest, forearm, upper back, and forehead with a 228 ventilated plastic capsule affixed at each site using adhesive rings, topical skin glue (Collodion 229 HV, Mavidon Medical Products, Lake Worth, FL, USA), and surgical tape. Anhydrous nitrogen 230 gas was passed through each capsule at a rate of 1 L·min -1 over the skin surface. Long vinyl 231 Nonthermal modulators of postexercise heat loss responses tubes connected the gas tank (positioned in the chamber) to the sweat capsule so that the gas 232 temperature was equilibrated to room temperature (~35˚C) before reaching the sweat capsule. 233
Capacitance hygrometry (Model HMT333, Vaisala, Helsinki, Finland) was used to measure 234 water content from the effluent air. Local sweat rate was calculated every 5-s as follows: 235
Local sweat rate= rh out *P H2O *f 100 T cap *krh in *P H2O *f 100 T a *k
where rh in and rh out are the relative humidity of air entering and leaving the capsule (%), P H2O is 237 the partial pressure of water vapour of air entering the capsule if 100% saturated (mmHg), f is the 238 flow rate through the rotameter (l·min Skin blood flow (perfusion units) was measured at the forearm and upper back using 242 laser-Doppler flow probes (PeriFlux System 5000, Perimed AB, Stockholm, Sweden) with an 243 integrated 7-laser array (Model 413, Perimed AB) that were each housed in a local heating 244 element (PF5020 Temperature Unit, Perimed AB) and affixed to the skin. Noteworthy, the 245 forearm was stabilized at the level of the heart throughout the baseline, exercise, and recovery 246 periods. At the end of each experimental session, both skin blood flow sites were heated to 42˚C 247 for ~10 min followed by an additional ~20 min at a temperature of 44˚C until a plateau was 248 observed for at least 2-3 min (maximum skin blood flow). Skin blood flow was calculated as a 249 percentage of the maximal skin blood flow response measured during the local heating to 44˚C. 250 Given that dry heat loss is primarily dependent on absolute blood flow to the skin and that our 251 study focus is on the recovery period, skin blood flow data are presented as a percent decrease 252 from the end of exercise to clearly delineate differences in the postexercise suppression of the 253
response. 254 Nonthermal modulators of postexercise heat loss responses
Mean arterial pressure was measured during baseline and recovery from the beat-to-beat 255 recording of the left middle finger arterial pressure waveform via the volume-clamp method (29) 256 using a Finometer (Finapres Medical Systems, Amsterdam, The Netherlands). Prior to each 257 measurement period, physiocal criteria (40) were used to calibrate the finger arterial size to the 258 point where the finger cuff air pressure equals the finger arterial blood pressure. With the left 259 arm supported at heart level, the brachial artery pressure reconstruction (12, 13) was calibrated 260
with an upper arm return-to-flow systolic pressure detection (3). Blood pressure was verified by 261 manual auscultation with the arm stabilized at the level of the heart using a validated mercury 262 column sphygmomanometer (Baumanometer Standby Model, WA Baum Co, Copiague, NY, 263 USA) after each Finometer calibration period (i.e., at baseline within 5 min postexercise). Blood 264 pressure was also measured via manual auscultation with the arm stabilized at the level of the 265 heart at every 5-min during exercise and at the end of the maximal skin blood flow protocol, and 266 calculated as mean arterial pressure (diastolic blood pressure plus one-third of pulse pressure). 267
Heart rate was recorded continuously and stored every 15-s using a Polar-coded wearlink 268 transmitter, Polar RS400 interface, and Polar Trainer 5 software (RS400, Polar Electro, 269
Kempele, Finland). Urine-specific gravity was assessed in duplicate from the urine samples 270 obtained at the start and end of each experimental session using a handheld total solids 271 refractometer (Model TS400, Reichter, Inc., Depew, NY, USA). 272
Plasma volume changes from baseline and plasma osmolality were determined from five 273 venous blood samples (~8 mL each) drawn at end of baseline, end-exercise, as well as prior to 274 the start (15-min of recovery), midway through (37.5-min of recovery), and at the end (60-min of 275 recovery) of the 45-min period of pressure application to the lower legs. These recovery time 276 points were selected to obtain a representation of plasma volume changes during the pressure 277 Nonthermal modulators of postexercise heat loss responses application period. Participants had been seated upright for a minimum of 60-min prior to 278 obtaining the baseline blood sample. The end-exercise sample was obtained within the final 1-279 min of exercise (i.e., participants were briskly walking upright at this time). Following a <5-min 280 transition period from the treadmill to the pressure box, participants had been seated for 10-, 281 32.5-, and 55-min for blood samples obtained at 15-, 37.5-, and 60-min of recovery, respectively. 282
Venous blood samples were collected without stasis into K2 EDTA Mean arterial pressure, heart rate, mean skin and esophageal temperatures and sweat rate 303 were analyzed using a two-way repeated-measures analysis of variance (2R-ANOVA) with the 304 factors of condition (five levels: natural recovery, LBPP, LBNP, ISO and HYP) and time (8 305 levels: baseline, end of exercise, and every 10-min of recovery). A 1R-ANOVA with the 306 repeated factor of condition (five levels) was used to analyze skin blood flow measured at 307 baseline and at the end of exercise. The percent decrease in skin blood flow from the end of 308 exercise was analyzed using a 2R-ANOVA with the factors of condition (five levels) and time 309 (six levels: every 10-min recovery). Plasma osmolality and the percent change in plasma volume 310 from baseline were analyzed using a 2R-ANOVA with the factors of condition (five levels) and 311 time (five levels: baseline, end of exercise, and 15-, 37.5-, and 60-min of recovery). Urine 312 specific gravity was analyzed using a 2R-ANOVA with the factors of condition (five levels) and 313 time (two levels: pre-and post-trial). Finally, pre-session body mass was analyzed using a 1R-314 ANOVA with the repeated factor of condition (five levels). When a significant interaction or 315 main effect was observed, post-hoc comparisons were carried out using paired samples t tests. 316
Due to having multiple experimental conditions, adjustments for multiple comparisons were not 317 performed and comparisons were limited to those with the natural recovery condition. For all 318 analyses, differences were considered significant when P ≤ 0.05. All statistical analyses were 319 performed using the statistical software package SPSS 22.0 for Windows (SPSS Inc. Chicago, 320 IL, USA). All values are presented as means ± standard error unless otherwise indicated. Due to 321 technical difficulties, esophageal temperature as well as upper back and forehead sweat rate are 322 presented for eight participants and chest sweat rate is presented for seven participants. 323
RESULTS

324
Hydration status 325
Pre-nude body mass was similar between conditions (natural recovery, 77.78 ± 5.67; LBPP, 326 78.35 ± 5.29; LBNP, 78.17 ± 5.35; ISO, 78.22 ± 5.58; HYP, 77.89 ± 5.70 kg; P = 0.50). In 327 addition, a main effect of time (P < 0.01), but no main effect of condition (P = 0.91) or 328 interaction (P = 0.07) was measured for urine-specific gravity. Specifically, participants were 329 similarly hydrated at the start and relatively less hydrated at the end of each experimental 330 condition (average urine-specific gravity increase across conditions: 0.009 ± 0.002; all P < 0.01). 331 332
Plasma volume changes and plasma osmolality 333
Plasma volume changes. An interaction of time and condition was detected for the percent 334 change in plasma volume (P < 0.01; Fig. 1a ). The infusion of saline maintained plasma volume 335 similar to baseline levels at the end of exercise (ISO: -0.9 ± 1.1; HYP: -0.6 ± 1.3%; P > 0.05) 336 whereas it was decreased during natural recovery (-8.9 ± 1.1%), LBPP (-8.9 ± 1.2%) and LBNP 337 (-9.1 ± 0.9%; all P < 0.01). Moreover, plasma volume in both ISO and HYP was greater 338 compared to the natural recovery condition throughout recovery by ~4.7 ± 0.8% (all P < 0.01). 339
The application of LBNP during recovery exacerbated the loss of plasma volume such that a 5.4 340 ± 0.8% greater reduction was observed relative to natural recovery (both P < 0.01). On the other 341 hand, the application of LBPP facilitated the restoration of plasma volume such that it was 342 increased by 3.4 ± 1.6% relative to natural recovery by the end of recovery, although not 343 significantly (P > 0.05). 344 Plasma osmolality. There was an interaction of time and condition measured for 345 osmolality (P < 0.01; Fig. 1b 
Hemodynamic responses 355
Mean arterial pressure. An interaction of condition and time was detected for mean arterial 356 pressure (P < 0.01; Fig. 2a ). Mean arterial pressure was similar between conditions at baseline 357 until 10 min of recovery inclusively (all P > 0.13). Mean arterial pressure at 10 min postexercise 358 was similar to baseline in all conditions (all P > 0.10). Thereafter, the application of LBPP 359 resulted in an elevation of mean arterial pressure by 10 ± 2 mmHg relative to natural recovery 360 starting from 20 min and lasted until the end of the recovery period (P < 0.02). Mean arterial 361 pressure in ISO was elevated relative to natural recovery at 50 min postexercise (P < 0.05); 362 however, no differences were detected in the LBNP and HYP conditions relative to natural 363 recovery (all P > 0.10). 364
Heart rate. There was an interaction of condition and time measured for heart rate (P < 365 0.01; Fig. 2b ). While heart rate did not differ between conditions at baseline, the infusion of 366 saline attenuated end-exercise heart rate relative to natural recovery (all P ≤ 0.05). In addition, 367 heart rate recovered more rapidly in ISO and with LBPP application such that it was reduced 368 compared to natural recovery at 20 min until the end of recovery by 7 ± 2 and 13 ± 2 bpm, 369 Nonthermal modulators of postexercise heat loss responses respectively (all P ≤ 0.04). In contrast, LBNP application caused an elevation in heart rate by 8 ± 370 3 bpm relative to natural recovery of by the end of recovery (all P < 0.03). Heart rate was not 371 different from natural recovery in HYP throughout recovery (all P > 0.10). 372
373
Temperature responses 374
Esophageal temperature. There was no interaction of condition and time detected for esophageal 375 temperature (P = 0.37, Fig. 3a ). However, a main effect of time was detected such that 376 esophageal temperature was increased by ~1.7 ± 0.1˚C relative to baseline at the end of exercise 377 and remained elevated by ~0.9 ± 0.1˚C at the end of recovery (all P < 0.01). 378
Mean skin temperature. An interaction of time and condition was measured for mean skin 379 temperature (P < 0.01; Fig. 3b ) such that mean skin temperature was similar between conditions 380 from baseline until 30 min of recovery inclusively (all P > 0.05). However, the infusion of 3.0% 381 NaCl resulted in an elevation of mean skin temperature by ~0.3 ± 0.1˚C relative to natural 382 recovery from 40 min until the end of recovery (P ≤ 0.03). 383 384
Heat loss responses 385
Sweating. An interaction of condition and time was detected for sweat rate measured at the chest, 386 forearm, and upper back (all P < 0.01), but not at the forehead (P = 0.15; Fig. 4 ). Sweat rate was 387 similar between conditions during baseline at all skin sites (all P > 0.05). During the ISO 388 condition, sweat rate measured at the end of exercise was augmented by 0.20 ± 0.08 mg·min To the best of our knowledge, this is the first study to examine the separate and combined effects 412 of plasma osmolality and baroreceptor loading status on postexercise sweating and skin blood 413 flow. Consistent with our first hypothesis, hyperosmolality as induced by the infusion of 3.0% 414 saline attenuated sweating at the upper back and to a lesser extent at the chest. However, it did 415 not impact forearm or forehead sweating, which may suggest regional heterogeneity in the 416 osmotic modulation of postexercise sweating. Interestingly, inducing baroreceptor loading via 417 0.9% saline infusion or prolonged LBPP application resulted in the attenuation of sweat rate 418 from 30 to 60 min of recovery at all sites but the forehead. Lastly, in support of our second 419 hypothesis, baroreceptor loading with LBPP application and to lesser extent the infusion of 420 saline maintained both forearm and upper back skin blood flow at elevated levels from 20 to 60 421 min of recovery; albeit no effect of plasma osmolality was observed. 422
423
Sweating 424
Until now, a role for osmoreceptors in the postexercise suppression of sweating had not been 425 explored. However, it is well established that recovery from exercise is associated with a state of 426 hyperosmolality (and therefore, activation of osmoreceptors) (4) and that hyperosmolality 427 negatively influences sweating during passive heat stress (2, 16, 24, 31, 36) Given that we included only young males, the findings of the current study cannot be generalized 504 to other populations groups such as females and/or older adults who display an impaired capacity 505 to dissipate heat (10, 23, 35) . In particular, both sex and ageing have been shown to 506 independently alter the osmotically-driven release of vasopressin, a hormone implicated in fluid 507 regulation, such that the concentration of vasopressin is reduced for a given level of plasma 508 osmolality in females and older adults when compared to males and young adults, respectively 509 (17, 34). These differences in fluid regulation suggest differences may also exist in the 510 osmoreceptor-mediated control of thermoeffector activity. While there are no sex-related 511 differences in the osmoreceptor modulation of sweating and skin blood flow during passive heat 512 stress (2), it remains to be elucidated whether sex-and age-related differences exist during and 513 following exercise. In addition, it should be noted that the lack of statistical differences in 514 esophageal temperature despite differences in heat loss responses between conditions may have 515 been confounded by the inherent vast differences in fluid distribution between conditions and 516 therefore heat transfer between body tissues. Lastly, while postexercise skin blood flow was 517 unaffected by baroreceptor unloading at esophageal temperatures ≤37.6˚C, this response may 518 have differed at a greater level of hyperthermia (i.e., >38˚C), as was observed by McGinn et al 519 (27) . Thus, a role for baroreceptor unloading in attenuating postexercise skin blood flow should 520 not be discounted, particularly in the context of high heat stress combined with severe 521 dehydration. 522 523
Perspectives and Significance 524
Several reports have attempted to delineate the relative contributions of nonthermal factors (e.g., 525
baro-, metabo-, metachoreceptors/muscle pump, and central command) to the suppression of 526 Nonthermal modulators of postexercise heat loss responses postexercise heat loss, with the vast majority of studies focusing on the role for baroreceptors 527 (21). Our findings reveal an osmotically-induced suppression of postexercise sweating that is 528 capable of overriding elevated levels of hyperthermia (i.e., core temperature elevation >0.9˚C). 529 Furthermore, although sweating was affected at regions of high sweat output (i.e., the upper back 530 and chest), it is unclear whether this would translate to a modulation of whole body heat loss 531 postexercise. While this response would serve to mitigate total body fluid loss during progressive 532 dehydration in order to promote the maintenance of blood volume and blood pressure, this comes 533 at the expense of thermoregulatory function as reductions in sweat rate impair the dissipation of 534 heat. Future research is warranted using direct whole-body calorimetry to assess whether 535 hyperosmolality associated with dehydration would induce meaningful changes in whole body 536 heat loss that would impact body heat storage, particularly during prolonged and/or intermittent 537 work in the heat when individuals are at greatest risk for dehydration and thermal strain. In this 538 context, factors that may alter skin wettedness (e.g., prolonged exercise, increased humidity, 539 changes in air velocity and skin temperature) and therefore the sweating response to 540 hyperosmolality should also be considered in future studies. 541
542
In summary, we show that plasma hyperosmolality attenuated sweating from the end of 543 exercise throughout 60-min of recovery. This effect was greatest at the torso such that the upper 544 back and chest sites were most susceptible to increases in plasma osmolality. However, this 545 response cannot be fully attributed to osmoreceptors alone given that baroreceptor loading via 546 saline infusion or LBPP application also attenuated sweating in the mid-to-late stages of 547 recovery (i.e., ≥30 min). In contrast, baroreceptor loading modulated skin blood flow in the mid-548 
